How do you predict which patients are most likely to have a positive response to Oxervate?
Answer from: at Community Practice
I don't think you can predict which patients are most likely to have a positive response, unfortunately. I think Stage 1 or early Stage 2 neurotrophic ulcers are the best scenarios to use this treatment.
Works great for peripheral nerve damage. HSV/VZV, burns, chronic dry eye/sicca/gvhd type patients.
For central nerve damage from tumor, stroke, or brain/face surgery never found any benefit.